Cargando…
Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney
Background: Given the limited treatment options available for kidney disease, a significant number of patients turn to alternative therapies, including traditional Chinese medicine. Among these therapies, the Fufang Shenhua tablet (SHT) has garnered attention for its effectiveness in addressing the...
Autores principales: | Li, Run, Shi, Chunru, Wei, Cuiting, Wang, Chao, Du, Hongjian, Hong, Quan, Chen, Xiangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113559/ https://www.ncbi.nlm.nih.gov/pubmed/37089929 http://dx.doi.org/10.3389/fphar.2023.1131635 |
Ejemplares similares
-
Effects of Physical Properties and Processing Methods on Astragaloside IV and Flavonoids Content in Astragali radix
por: Chien, Mei-Yin, et al.
Publicado: (2022) -
An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer
por: Yang, Bing, et al.
Publicado: (2021) -
Protective effect of astragalosides from Radix Astragali on adriamycin-induced podocyte injury
por: Sai, Yi-Pa, et al.
Publicado: (2018) -
Neuroprotective effect of Astragali Radix on cerebral infarction based on proteomics
por: Li, Ying, et al.
Publicado: (2023) -
Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis
por: Geng, Wenjia, et al.
Publicado: (2016)